Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,260 | -72,891 | -51,834 | -194,912 | -37,300 |
| Accounts payable and accrued liabilities | 2,807 | 725 | -766 | -1,965 | 347 |
| Other Working Capital | 5,547 | -1,828 | 2,093 | -3,305 | 3,367 |
| Other Operating Activity | 4,694 | 5,549 | 6,974 | 170,031 | 1,101 |
| Operating Cash Flow | $-81,212 | $-68,445 | $-43,533 | $-30,151 | $-32,485 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -191,538 | 135,077 | -167,038 | -19,000 | 6,333 |
| PPE Investments | -325 | -25 | -91 | -21 | -33 |
| Net Acquisitions | N/A | N/A | N/A | 6,466 | N/A |
| Investing Cash Flow | $-191,863 | $135,052 | $-167,129 | $-12,555 | $6,300 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 157,202 | 88,398 | 144,721 | 104,284 | 40,860 |
| Financing Cash Flow | $157,202 | $88,398 | $144,721 | $104,284 | $40,860 |
| Beginning Cash Position | 175,693 | 20,688 | 86,629 | 25,051 | 10,376 |
| End Cash Position | 59,820 | 175,693 | 20,688 | 86,629 | 25,051 |
| Net Cash Flow | $-115,873 | $155,005 | $-65,941 | $61,578 | $14,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,212 | -68,445 | -43,533 | -30,151 | -32,485 |
| Capital Expenditure | -325 | -25 | -91 | -21 | -33 |
| Free Cash Flow | -81,537 | -68,470 | -43,624 | -30,172 | -32,518 |